171 related articles for article (PubMed ID: 16935383)
21. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma.
Sabit H; Tsuneyama K; Shimonishi T; Harada K; Cheng J; Ida H; Saku T; Saito K; Nakanuma Y
Pathol Int; 2001 Apr; 51(4):248-56. PubMed ID: 11350606
[TBL] [Abstract][Full Text] [Related]
22. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography.
Dobashi A; Imazu H; Tatsumi N; Okabe M; Ang TL; Tajiri H
Scand J Gastroenterol; 2013 Jul; 48(7):848-55. PubMed ID: 23721191
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Zimmerman RL; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
[TBL] [Abstract][Full Text] [Related]
25. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree.
Lepreux S; Bioulac-Sage P; Chevet E
Liver Int; 2011 Mar; 31(3):322-8. PubMed ID: 21281432
[TBL] [Abstract][Full Text] [Related]
27. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
28. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
30. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.
Zhang KJ; Wang DS; Zhang SY; Jiao XL; Li CW; Wang XS; Yu QC; Cui HN
J Exp Clin Cancer Res; 2010 Jul; 29(1):88. PubMed ID: 20594328
[TBL] [Abstract][Full Text] [Related]
31. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
[TBL] [Abstract][Full Text] [Related]
32. Tricellulin expression and its prognostic significance in primary liver carcinomas.
Somorácz A; Korompay A; Törzsök P; Patonai A; Erdélyi-Belle B; Lotz G; Schaff Z; Kiss A
Pathol Oncol Res; 2014 Oct; 20(4):755-64. PubMed ID: 24652413
[TBL] [Abstract][Full Text] [Related]
33. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
[TBL] [Abstract][Full Text] [Related]
34. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.
Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727
[TBL] [Abstract][Full Text] [Related]
35. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
Lai GH; Radaeva S; Nakamura T; Sirica AE
Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
[TBL] [Abstract][Full Text] [Related]
37. Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours.
Altimari A; Fiorentino M; Gabusi E; Gruppioni E; Corti B; D'Errico A; Grigioni WF
Dig Liver Dis; 2003 May; 35(5):332-8. PubMed ID: 12846405
[TBL] [Abstract][Full Text] [Related]
38. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
[TBL] [Abstract][Full Text] [Related]
39. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
40. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
